血管紧张素转换酶抑制剂(ACE—I)的发展是当代心血管药理学进展中的一个重要事件,由于其不影响葡萄糖耐量、血尿酸、胆固醇水平,在高血压、充血性心衰的治疗中,这类药的应用迅速增加。然而,随着应用的日趋广泛,不良反应的报道也逐年增多,为了引起医务工作者的重视,现将近年来有关该药不良反应的报道,作一简要综述。 The development of angiotensin converting enzyme inhibitors (ACE-I) is an important event in the development of contemporary cardiovascular pharmacology as it does not affect glucose tolerance, serum uric acid, cholesterol levels, and treatment of hypertension, congestive heart failure In the rapid increase in the use of such drugs. However, with the wide application, the reports of adverse reactions have also increased year by year. In order to arouse the attention of medical workers, the recent reports on the adverse drug reactions are briefly reviewed.